MYC targets, unfolded protein response, and epithelial-mesenchymal transition (EMT) were upregulated, whereas the late response to estrogen, bile acid metabolism, and the KRAS signaling DN pathway was downregulated in the patients in the COAD group (Figure 3C). This evidence concerns the gene MYC and colon adenocarcinoma.